Postinduction molecular MRD identifies patients with <i>NPM1</i> AML who benefit from allogeneic transplant in first remission
Jad Othman(King's College London), Nigel H. Russell(Nottingham University Hospitals NHS Trust), Claire Arnold(University of Ulster), Jelena Jovanović(Centre de Recherche Jean Pierre Aubert), Alan K. Burnett(Cardiff University), Adam Ivey(The Alfred Hospital), Sean Johnson(Cardiff University), Panagiotis Kottaridis(University College Hospital), Amanda Gilkes(Cardiff University), Sylvie Freeman(University of Birmingham), Manohursingh Runglall(King's College London), Mike Dennis(The Christie NHS Foundation Trust), Joanna Canham(Cardiff University), Ian Thomas(Cardiff University), Ulrik Malthe Overgaard(Copenhagen University Hospital), Hans Beier Ommen(Centre de Recherche Jean Pierre Aubert), Nicola Potter(European Bioinformatics Institute), Richard Dillon(King's College London), Jamie Cavenagh(St Bartholomew's Hospital), Charlotte S. Wilhelm-Benartzi(Cardiff University)
Cited by 75
Related Papers
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k